Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Deferred Taxes (2022 - 2024)

Verastem (VSTM) posted quarterly Deferred Taxes of -$327000.0 for Q1 2024, down 147.19% year-over-year from $693000.0 in Q2 2023, and up 53.81% quarter-over-quarter from -$708000.0 in Q4 2023.

Analysis

Verastem (VSTM) Deferred Taxes (2022 - 2024) Analysis & Trends

Verastem's Deferred Taxes history runs 3 years deep, the most recent figure standing at -$327000.0 for Q1 2024.

  • In Q1 2024, Deferred Taxes fell 147.19% year-over-year to -$327000.0; the TTM figure through Dec 2024 stood at -$327000.0 (up 14.62% YoY), while the FY2024 annual figure was -$327000.0, up 14.62% from the prior year.
  • Deferred Taxes for Q1 2024 stood at -$327000.0, up from -$708000.0 in the prior quarter.
  • The five-year high for Deferred Taxes was $693000.0 in Q1 2023, with the low at -$708000.0 in Q4 2023.
  • The 3-year median for Deferred Taxes is -$291000.0 (2022), against an average of -$160833.3.
  • The sharpest annual moves came in 2023 and 2024: Deferred Taxes plunged 177.65% in 2023, then sank 147.19% in 2024.
  • Verastem's Deferred Taxes stood at -$255000.0 in 2022, then slumped by 177.65% to -$708000.0 in 2023, then soared by 53.81% to -$327000.0 in 2024.
  • Business Quant data shows VSTM's Deferred Taxes at -$327000.0 in Q1 2024, -$708000.0 in Q4 2023, and $291000.0 in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -69.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 194.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.66 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -327,000.00
Dec 31, 2023 -708,000.00
Sep 30, 2023 291,000.00
Jun 30, 2023 -659,000.00
Mar 31, 2023 693,000.00
Dec 31, 2022 -255,000.00